 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter C - Drugs: General |
|
|
Part 201 - Labeling |
|
|
Subpart A - General Labeling Provisions |
| § 201.1 - Drugs; name and place of business of manufacturer, packer, or distributor. |
| § 201.2 - Drugs and devices; National Drug Code numbers. |
| § 201.5 - Drugs; adequate directions for use. |
| § 201.6 - Drugs; misleading statements. |
| § 201.10 - Drugs; statement of ingredients. |
| § 201.15 - Drugs; prominence of required label statements. |
| § 201.16 - Drugs; Spanish-language version of certain required statements. |
| § 201.17 - Drugs; location of expiration date. |
| § 201.18 - Drugs; significance of control numbers. |
| § 201.19 - Drugs; use of term “infant”. |
| § 201.20 - Declaration of presence of FD&C Yellow No. 5 and/or FD&C Yellow No. 6 in certain drugs for human use. |
| § 201.21 - Declaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use. |
| § 201.22 - Prescription drugs containing sulfites; required warning statements. |
| § 201.23 - Required pediatric studies. |
| § 201.24 - Labeling for systemic antibacterial drug products. |
| § 201.25 - Bar code label requirements. |
| § 201.26 - Exceptions or alternatives to labeling requirements for human drug products held by the Strategic National Stockpile. |